ArticleMicrobiology spectrum2026
Characterization of novel phage Henuyfy11N: a potential therapeutic agent against extended-spectrum β-lactamase (ESBL)-producing
Xinwei Zhang, Jiaqi He, Dongliang Qiao, Qiming Li, Zhigang Liu, Li Wang
Abstract read
In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Xinwei ZhangHenan Province Engineering Technology Research Center of Rapid-Accuracy Medical Diagnostics, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, China.
Jiaqi HeHenan Province Engineering Technology Research Center of Rapid-Accuracy Medical Diagnostics, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, China.
Dongliang QiaoHenan Province Engineering Technology Research Center of Rapid-Accuracy Medical Diagnostics, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, China.
Qiming LiHenan Province Engineering Technology Research Center of Rapid-Accuracy Medical Diagnostics, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, China.ORCID 0000-0002-6916-3954 Zhigang LiuHenan Province Engineering Technology Research Center of Rapid-Accuracy Medical Diagnostics, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, China.
Li WangHenan Province Engineering Technology Research Center of Rapid-Accuracy Medical Diagnostics, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, China.ORCID 0009-0001-1822-5887 Funding
Health Commission of Henan Province LHGJ20240383Health Commission of Henan Province SBGJ202402084, SBGJ202302089Science and Technology Department of Henan Province 30389
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Bacteriophagesbeta-LactamasesColiphagesEscherichia coliEscherichia coli InfectionsPhage TherapyAnimalsAnti-Bacterial AgentsBiofilmsGenome, ViralHost SpecificityMicePhylogenyAnti-Bacterial Agentsbeta-LactamasesEscherichia phageextended-spectrum β-lactamasephage therapy
Identifiers
PMID42037381
PMCPMC13228064
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390